Summary
Obesity is associated with an increased risk of many major chronic diseases. We estimated the economic costs of obesity-associated non-insulin-dependent diabetes mellitus, cardiovascular disease, gallbladder disease, cancer, and musculoskeletal disorders in 1990 US dollars, using a prevalence-based approach to cost-of-illness. In addition to direct costs, indirect costs were also estimated. The indirect cost of morbidity was estimated by calculating the costs associated with work days lost, and mortality costs were estimated on the basis of lifetime earnings lost.
In 1990, the direct cost of obesity-associated disease in the US was $US45.8 billion, and the indirect cost of obesity was estimated to be $US23.0 billion. Therefore the total economic cost of obesity was estimated to be $US68.8 billion in 1990.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andres R, Elahi D, Tobin JO, Muller DC, Porant L. Impact of age on weight goals. Annals of Internal Medicine 103: 1030–1033, 1985
Anon. The Surgeon’s General report on nutrition and health (PHS) 88-50210. US Dept of Health and Human Services, US Government Printing Office, Washington, DC, October, 1988
Colditz GA. The economic costs of obesity. American Journal of Clinical Nutrition 55: 503S–507S, 1992
Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, et al. Weight as a risk factor for clinical diabetes in women. American Journal of Epidemiology 132: 501–513, 1990
Handbook of Labor Statistics, U.S. Department of Labor, Bureau of Labor Statistics, Bulletin 2340, August 1989
Hodgson TA, Kopstein AN. Health care expenditures for major diseases in 1980. Health Care Financial Review 5: 1–12, 1984
Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA. The economic costs of non-insulin-dependent diabetes mellitus 262: 2708–2713, 1989
Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. Journal of Clinical Epidemiology 32: 563–576, 1979
Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, et al. A prospective study of obesity and risk of coronary heart disease in women. New England Journal of Medicine 322: 882–889, 1990
Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity. A reassessment. Journal of the American Medical Association 257: 353–359, 1987
Melton LJ, Palumbo PJ, Dwyer MS, Chu CP. Impact of changes in diagnostic criteria on the apparent history of diabetes mellitus. American Journal of Epidemiology 117: 559–565, 1983
Millar WJ, Stephans T. The prevalence of overweight and obesity in Britain, Canada, and the United States. American Journal of Public Health 77: 38–41, 1987
Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financial Review 7: 61–80, 1985
Seidell JC, Deerenberg I. Obesity in Europe: prevalence and consequences for use of medical care. PharmacoEconomics ((to come))
Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. American Journal of Clinical Nutrition 55: 652–658, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolf, A.M., Colditz, G.A. The Cost of Obesity. Pharmacoeconomics 5 (Suppl 1), 34–37 (1994). https://doi.org/10.2165/00019053-199400051-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199400051-00007